Top compounds associated with response to IPO4


Feature Type Standardized
Nominal ANOVA
mRNA N9-isopropylolomoucine CTRPv2 pan-cancer AAC 0.027 0.5
mRNA Nilotinib CTRPv2 pan-cancer AAC -0.027 0.5
mRNA PF-184 CTRPv2 pan-cancer AAC 0.024 0.5
mRNA OSI-027 CTRPv2 pan-cancer AAC 0.026 0.5
mRNA paclitaxel UHNBreast pan-cancer AAC 0.23 0.5
mRNA BRD-K13999467 CTRPv2 pan-cancer AAC -0.026 0.5
mRNA lomeguatrib CTRPv2 pan-cancer AAC -0.027 0.5
mRNA BRD-K27188169 CTRPv2 pan-cancer AAC 0.039 0.5
mRNA vorapaxar CTRPv2 pan-cancer AAC -0.027 0.5
mRNA necrosulfonamide CTRPv2 pan-cancer AAC -0.028 0.5
Download CSV